SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
KLDO
--
0.00%
--
Kaleido Biosciences launches study of KB109 in COVID-19 patients
Seeking Alpha - Article · 07/23 12:13
Morgan Stanley Maintains Equal-Weight on Kaleido Biosciences, Lowers Price Target to $7
Morgan Stanley maintains Kaleido Biosciences (NASDAQ:KLDO) with a Equal-Weight and lowers the price target from $8 to $7.
Benzinga · 07/15 14:37
Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
PR Newswire · 07/07 13:00
Kaleido Biosciences Announces CEO Leadership Transition
GlobeNewswire · 06/16 21:45
Kaleido Biosciences announces CEO leadership transition
Seeking Alpha - Article · 06/16 20:58
Kaleido Biosciences Reports Pres, CEO Alison Lawton To Step Down; Chair Mike Bonney To Lead Pres, CEO Office
Benzinga · 06/16 20:47
Kaleido Biosciences Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting
GlobeNewswire · 06/08 13:30
Theodose Melas-Kyriazi Is The Independent Director of Kaleido Biosciences, Inc. (NASDAQ:KLDO) And Just Spent US$250k On Shares
Simply Wall St. · 06/07 13:54
Kaleido Biosciences to Present During the Goldman Sachs 41st Annual Global Healthcare Conference
GlobeNewswire · 06/04 13:30
Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Kaleido Biosciences Shares Plunge
Toward the end of trading Tuesday, the Dow traded up 0.61% to 25630.00 while the NASDAQ rose 0.11% to 9562.43. The S&P also rose, gaining 0.39% to 3067.67.
Benzinga · 06/02 18:30
MGI, WWR, NNA and ADRO among midday movers
Seeking Alpha - Article · 06/02 16:46
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Tenax Therapeutics Inc (NASDAQ: TENX) shares climbed 42.3% to $2.07 after the company reported results from its Phase 2 trial of Levosimendan. The trial demonstrated a significant reduction in right atrial and pulmonary capillary wedge pressures.
Benzinga · 06/02 16:21
Mid-Day Market Update: NASDAQ Turns Lower; MoneyGram International Shares Jump
Midway through trading Tuesday, the Dow traded up 0.47% to 25595.48 while the NASDAQ fell 0.54% to 9500.51. The S&P also rose, gaining 0.12% to 3059.36.
Benzinga · 06/02 16:10
Mid-Morning Market Update: Markets Open Higher; Donaldson Reports Mixed Q3 Results
Following the market opening Tuesday, the Dow traded up 0.67% to 25645.59 while the NASDAQ rose 0.07% to 9558.84. The S&P also rose, gaining 0.32% to 3065.47.
Benzinga · 06/02 14:20
The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1)
Benzinga · 06/02 11:45
Kaleido Biosciences Prices 4.75M Share Public Offering of Common Stock @$7.50/Share
Kaleido Biosciences, Inc. (NASDAQ: KLDO) announced the pricing of an underwritten public offering of 4,750,000 shares of its common stock at a public offering price of $7.50 per share.
Benzinga · 06/02 09:39
Kaleido Bio prices equity offering at $7.50
Seeking Alpha - Article · 06/02 08:13
Kaleido Biosciences readies equity offering
Kaleido Biosciences (NASDAQ:KLDO) initiates a $30M public offering of common stock. Price, volume and terms have yet to be announced. Shares down 5% after-
seekingalpha · 06/02 01:25
Kaleido Biosciences Announces Proposed Public Offering of Common Stock
GlobeNewswire · 06/01 21:17
Kaleido Biosciences Announces Proposed $30M Public Offering of Common Stock
Benzinga · 06/01 20:18